Nicotinic Acetylcholine Receptor Expression in Merkel Cell Carcinoma Is Associated With Clinical and Histopathologic...

Area of Science:

• Oncology
• Neuroscience
• Cell Biology

Background:

• Merkel cell carcinoma (MCC) is a rare, aggressive skin cancer with neuroendocrine features.
• Neural crest cells, expressing acetylcholine receptors (AChRs), are proposed cell-of-origin candidates for MCC.
• The role of nicotinic acetylcholine receptors (nAChRs) in MCC remains unexplored.

Purpose of the Study:

• To investigate the expression of nAChRs in MCC.
• To determine if nAChR expression correlates with patient characteristics.

Main Methods:

• Immunohistochemical analysis of 71 MCC tissue samples.
• Antibodies targeting α3, α5, and α7 nAChR subunits were utilized.
• Median follow-up of 29.8 months.

Main Results:

• The majority of MCC cases expressed α3 (83%), α5 (100%), and α7 (88%) nAChR subunits.
• Immunoreactivity varied in location (cytoplasmic, nuclear/peri-nuclear) and intensity.
• Significant correlations were found between nAChR immunoreactivity and clinical/histopathologic parameters.

Conclusions:

• MCC exhibits features consistent with neural crest cell differentiation.
• The presence of nAChRs suggests potential therapeutic targets for MCC.